Lite Strategy (LITS) Tax Provisions (2011 - 2018)
Lite Strategy (LITS) posted quarterly Tax Provisions of $1000.0 for Q3 2018, little changed year-over-year from $1000.0 in Q3 2017, and little changed quarter-over-quarter from $1000.0 in Q3 2017.
Lite Strategy (LITS) Tax Provisions (2011 - 2018) Analysis & Trends
Lite Strategy's Tax Provisions history runs 8 years deep, the most recent figure standing at $1000.0 for Q3 2018.
- In Q3 2018, Tax Provisions changed 0.0% year-over-year to $1000.0; the TTM figure through Jun 2019 stood at $1000.0 (changed 0.0% YoY), while the FY2022 annual figure was -$191000.0, up 97.8% from the prior year.
- Tax Provisions for Q3 2018 stood at $1000.0, roughly flat from $1000.0 in the prior quarter.
- The five-year high for Tax Provisions was $1000.0 in Q4 2014, with the low at -$11.1 million in Q2 2015.
- The 5-year median for Tax Provisions is $1000.0 (2014), against an average of -$1.7 million.
- The sharpest annual moves came in 2015 and 2016: Tax Provisions tumbled 602.27% in 2015, then surged 89.06% in 2016.
- Lite Strategy's Tax Provisions stood at $1000.0 in 2014, then changed by 0.0% to $1000.0 in 2015, then changed by 0.0% to $1000.0 in 2016, then changed by 0.0% to $1000.0 in 2017, then changed by 0.0% to $1000.0 in 2018.
- Business Quant data shows LITS's Tax Provisions at $1000.0 in Q3 2018, $1000.0 in Q3 2017, and $1000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 1,000.00 |
| Sep 30, 2017 | 1,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Jun 30, 2016 | -1.22 Mn |
| Sep 30, 2015 | 1,000.00 |
| Jun 30, 2015 | -11.12 Mn |
| Dec 31, 2014 | 1,000.00 |
| Jun 30, 2014 | -1.58 Mn |
| Sep 30, 2013 | 1,000.00 |
| Jun 30, 2013 | -3.80 Mn |
| Sep 30, 2012 | 1,000.00 |
| Jun 30, 2012 | -2.56 Mn |
| Sep 30, 2011 | 1,000.00 |